Hyperlipidemia, statin use and dengue severity
Multiple in vitro and mice model studies suggest statins may attenuate dengue severity. However, little is known about statin use and dengue severity in adult dengue patients with hyperlipidemia. We conducted a retrospective cohort study from 2004–2008 and 2012–2013 in Tan Tock Seng Hospital, Singap...
Saved in:
Main Authors: | Chia, Po Ying, Htun, Htet Lin, Ling, Wei Ping, Leo, Yee Sin, Yeo, Tsin Wen, Lye, David Chien Boon |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/88912 http://hdl.handle.net/10220/46983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Hyperlipidemia, statin use and dengue severity
by: Chia, P.Y, et al.
Published: (2020) -
Metformin use and severe dengue in diabetic adults
by: Lye, David Chien, et al.
Published: (2018) -
Differences in clinical features and dengue severity between local and migrant Chinese with dengue infection in Singapore
by: Xu, Chuanhui, et al.
Published: (2018) -
Association of systemic vitamin D on the course of dengue virus infection in adults: a single-centre dengue cohort study at a large institution in Singapore.
by: Sadarangani, Sapna P, et al.
Published: (2023) -
Febrile phase soluble urokinase plasminogen activator receptor and olfactomedin 4 as prognostic biomarkers for severe dengue in adults
by: Teo, Andrew, et al.
Published: (2024)